Papua New Guinea
Diabetes country report 2000 — 2050
Number of adults (20–79 years) with diabetes in Papua New Guinea (PG)
2000 | 378.3 thousand |
2011 | 216.8 thousand |
2024 | 838.0 thousand |
2050 | 1.4 million |
Papua New Guinea is one of the 37 countries and territories in the Western Pacific Region.
Data source(s) used for the diabetes estimates in adults:
- WHO STEPS 2008
Diabetes estimates (20-79 y) | ||||
---|---|---|---|---|
People with diabetes, in 1,000s | 378.3 | 216.8 | 838.0 | 1,403.5 |
Age-standardised prevalence of diabetes, % | 15.5 | 7.6 | 14.1 | 14.5 |
Proportion of people with undiagnosed diabetes, % | - | - | 73.2 | - |
People with undiagnosed diabetes, in 1,000s | - | - | 613.1 | - |
Impaired Fasting Glucose (IFG) | ||||
---|---|---|---|---|
People with IFG, in 1,000s | - | - | 662.8 | 1,143.0 |
Age-standardised prevalence of IFG, % | - | - | 11.5 | 12.0 |
Impaired Glucose Tolerance (IGT) | ||||
---|---|---|---|---|
People with IGT, in 1,000s | - | 262.7 | 380.3 | 699.9 |
Age-standardised prevalence of IGT, % | - | 8.3 | 7.5 | 8.0 |
Mortality attributable to diabetes (20-79 y) | ||||
---|---|---|---|---|
Deaths attributable to diabetes | - | 5,189.0 | 4,516.4 | - |
Proportion of diabetes-related deaths in people 20-79 y, % | - | - | 9.3 | - |
Hyperglycaemia in pregnancy (HIP) (20-49 y) | ||||
---|---|---|---|---|
Live births affected by HIP | - | - | - | - |
Prevalence of gestational diabetes mellitus (GDM), % | - | - | - | - |
Live births affected by other types of diabetes first detected in pregnancy | - | - | - | - |
Live births affected by other types of diabetes detected prior to pregnancy | - | - | - | - |
Diabetes-related health expenditure | ||||
---|---|---|---|---|
Total diabetes-related health expenditure, USD million | - | - | 129.4 | 192.4 |
Total diabetes-related health expenditure, ID million | - | - | 205.5 | 305.6 |
Diabetes-related health expenditure per person, USD | - | 68.0 | 154.4 | 137.1 |
Diabetes-related health expenditure per person, ID | - | - | 245.3 | 217.8 |
Type 1 diabetes estimates in children and adolescents | ||||
---|---|---|---|---|
People with type 1 diabetes (all age groups) | - | - | 333.0 | - |
People with type 1 diabetes (0-19 y) | - | - | 133.7 | - |
Demographics | ||||
---|---|---|---|---|
Total adult population (20-79 y), in 1,000s | 2,438.0 | 3,553.7 | 5,902.4 | 9,646.3 |
Population of children and adolescents (0-19 y) | - | - | 4,586,565.0 | - |
Diabetes estimates (20-79 y) | |
---|---|
People with diabetes, in 1,000s | 378.3 |
Age-standardised prevalence of diabetes, % | 15.5 |
Proportion of people with undiagnosed diabetes, % | - |
People with undiagnosed diabetes, in 1,000s | - |
Impaired Fasting Glucose (IFG) | |
---|---|
People with IFG, in 1,000s | - |
Age-standardised prevalence of IFG, % | - |
Impaired Glucose Tolerance (IGT) | |
---|---|
People with IGT, in 1,000s | - |
Age-standardised prevalence of IGT, % | - |
Mortality attributable to diabetes (20-79 y) | |
---|---|
Deaths attributable to diabetes | - |
Proportion of diabetes-related deaths in people 20-79 y, % | - |
Hyperglycaemia in pregnancy (HIP) (20-49 y) | |
---|---|
Live births affected by HIP | - |
Prevalence of gestational diabetes mellitus (GDM), % | - |
Live births affected by other types of diabetes first detected in pregnancy | - |
Live births affected by other types of diabetes detected prior to pregnancy | - |
Diabetes-related health expenditure | |
---|---|
Total diabetes-related health expenditure, USD million | - |
Total diabetes-related health expenditure, ID million | - |
Diabetes-related health expenditure per person, USD | - |
Diabetes-related health expenditure per person, ID | - |
Type 1 diabetes estimates in children and adolescents | |
---|---|
People with type 1 diabetes (all age groups) | - |
People with type 1 diabetes (0-19 y) | - |
Demographics | |
---|---|
Total adult population (20-79 y), in 1,000s | 2,438.0 |
Population of children and adolescents (0-19 y) | - |